Industry executives from across the healthcare continuum, including health plans, pharma/life sciences, government agencies, technology innovators and provider organizations, joined a powerful lineup of the nation’s most influential voices sharing thought-provoking keynote addresses, informative panel discussions and insightful breakout sessions gathered in Washington, D.C., for the 8th annual Inovalon Client Congress to address the programs and perspectives shaping the healthcare ecosystem.
Dr. Keith Dunleavy, Inovalon’s CEO, opened this year’s event addressing the shift from volume- to value-based care paradigms and the integral role and measurable impact of data driven insights, advanced analytics and technological innovations play in the achievement of improved quality and utilization across the healthcare continuum.
Building on these themes, esteemed keynote speakers offered thought-provoking addresses, touching on the programs and perspectives shaping the industry. Speakers included:
• Dr. Vindell Washington, HHS National Coordinator for Health Information Technology
• Marilyn Tavenner, former Centers for Medicare & Medicaid Services administrator and President and CEO of America's Health Insurance Plans
• Dr. Adaeze Enekwechi, Associate Director for Health Programs at the White House Office of Management and Budget
• Daniel Mendelson, President, Avalere
• Peggy O’Kane, Founder and President of the National Committee for Quality Assurance
• Lori Reilly, Executive Vice President for Policy, Research and Membership at the Pharmaceutical Research and Manufacturers of America
• Susan Dentzer, President and Chief Executive Officer of the Network for Excellence in Health Innovation served as moderator
Client Congress offered both big picture, strategic insights, along with real-world, tactical insights that guests could immediately apply to thrive in this evolving healthcare ecosystem.
• How Big Data can drive value and cost controls by targeting care to the right patients at the right time to improve clinical and quality outcomes, utilization efficiency and financial performance critical to payers, providers, ACOs, pharma/life sciences manufacturers and patients.
• The role of the provider as they take on more risk in alternative payment models and gain sharing agreements and analyze provider behavior to customize targeted interventions to improve diagnosis, treatment outcomes, documentation and engagement.
• How payers and pharma/life sciences manufacturers are approaching outcomes-based payment arrangements to make valuable new innovative therapies available to patients at a manageable cost.
• The future of consumerism in the industry and how the evolution of benefit design is intended to influence behavior to generate greater price competition and control cost of care.
To all those who participated in Client Congress 2016 representing health plans, pharma, life sciences, government agencies, partners, academics, ACOs, health systems and researchers, thank you for joining the discussion on technological innovations and best practices driving measurable impact across the healthcare landscape.